SYNAPCELL SPONSORS CNS XCHANGE 2023
HubXchange’s Europe CNS Therapeutics Xchange 2023, brings together executives from pharma and biotech to address and find solutions to the key issues faced in developing CNS therapies.
Discussion topics will cover Preclinical, Clinical Studies and Drug Delivery. Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking with your peers!
✈ 🇨🇭 VENUE DETAILS:
Hilton Zurich Airport Hotel, Hohenbuehlstrasse 10 – 8152 Opfikon, Switzerland
Meet our Panelists
Roundtable at a glance
There is a chasm between preclinical and clinical drug development caused mainly by lack of translation and efficacy, lack of true target validation and lack of complete drug optimization processes.
We want to hear your insights on the best way to anticipate these difficulties when crossing the gap between preclinical and clinical testing.
How to prepare a clinical phase 1 by doing the right preclinical studies?
👉 What are the goals of a clinical phase 1?
👉 Can we transpose the tools used in preclinical studies to phase 1 clinical trial?
👉 How to optimize and increase the success of phase 1 clinical trials by doing the right preclinical studies?
We look forward to discussing with you there !